Ketogenic diet: overview, types, and possible anti-seizure mechanisms

References

• Engel Jr J. Approaches to refractory epilepsy. Ann Indian Acad Neurol. 2014;17(Suppl 1):S12–7.
   PubMed Web of Science ®Google Scholar
• Milczarek O, Jarocha D, Starowicz-Filip A, Kwiatkowski S, Badyra B, Majka M. Multiple autologous bone marrow-derived CD271+ mesenchymal stem cell transplantation overcomes drug-resistant epilepsy in children. Stem Cells Transl Med. 2018;7(1):20–33.
   PubMed Web of Science ®Google Scholar
• Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. Jama. 2010;303(14):1401–9.
   PubMed Web of Science ®Google Scholar
• Lauritzen F, Eid T, Bergersen LH. Monocarboxylate transporters in temporal lobe epilepsy: roles of lactate and ketogenic diet. Brain Structure and Function. 2015;220(1):1–12.
   PubMed Web of Science ®Google Scholar
• Mehdizadeh A, Barzegar M, Negargar S, Yahyavi A, Raeisi S. The current and emerging therapeutic approaches in drug-resistant epilepsy management. Acta Neurol Belg. 2019;119(2):155–162.
   PubMed Web of Science ®Google Scholar
• Sheng J, Liu S, Qin H, Li B, Zhang X. Drug-resistant epilepsy and surgery. Curr Neuropharmacol. 2018;16(1):17–28.
   PubMed Web of Science ®Google Scholar
• Bough K. Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet. Epilepsia. 2008;49(s8):91–3.
   PubMed Web of Science ®Google Scholar
• Gonzalez FL, Osorio XR, Rein AG-N, Martinez MC, Fernandez JS, Haba VV, et al. Drug-resistant epilepsy: definition and treatment alternatives. Neurología (English Edition). 2015;30(7):439–46.
   PubMed Web of Science ®Google Scholar
• Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. The Lancet Neurology. 2018;17(1):84–93.
   PubMed Web of Science ®Google Scholar
• Wilder R. The effects of ketonemia on the course of epilepsy. InMayo Clin Proc. 1921;2:307–308.
   Google Scholar
• Kossoff EH, Shields WD. Nonpharmacologic care for patients with lennox-gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia. 2014;55(s4):29–33.
   PubMed Web of Science ®Google Scholar
• Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatr Neurol. 2007;36(5):281–92.
   PubMed Web of Science ®Google Scholar
• Pfeifer HH, Lyczkowski DA, Thiele EA. Low glycemic index treatment: implementation and new insights into efficacy. Epilepsia. 2008;49(s8):42–5.
   PubMed Web of Science ®Google Scholar
• Zamani GR, Mohammadi M, Ashrafi MR, Karimi P, Mahmoudi M, Badv RS, et al. The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol Belg. 2016;116(4):529–34.
   PubMed Web of Science ®Google Scholar
• de Lima PA, Prudêncio MB, Murakami DK, de Brito Sampaio LP, Neto AMF, Damasceno NRT. Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Nutrition. 2017;33:271–7.
   PubMed Web of Science ®Google Scholar
• Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics. 2000;105(4):e46.
   PubMed Web of Science ®Google Scholar
• Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol. 2006;35(1):1–5.
   PubMed Web of Science ®Google Scholar
• Liu Y-M, Wang H-S. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J. 2013;36(1):9–15.
   PubMedGoogle Scholar
• YmC L. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia. 2008;49:33–6.
   Web of Science ®Google Scholar
• Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009;50(5):1109–17.
   PubMed Web of Science ®Google Scholar
• Khabbush A, Orford M, Tsai YC, Rutherford T, O’donnell M, Eaton S, et al. Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium-chain triglyceride ketogenic diet. Epilepsia. 2017;58(8):1423–9.
   PubMed Web of Science ®Google Scholar
• Zupec-Kania B, Neal E, Schultz R, Roan ME, Turner Z, Welborn M. An update on diets in clinical practice. J Child Neurol. 2013;28(8):1015–26.
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61(12):1789–91.
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia. 2008;49(s8):37–41.
   PubMed Web of Science ®Google Scholar
• Auvin S. Non-pharmacological medical treatment in pediatric epilepsies. Rev Neurol (Paris). 2016;172(3):182–5.
   PubMed Web of Science ®Google Scholar
• Sharma S, Goel S, Jain P, Agarwala A, Aneja S. Evaluation of a simplified modified Atkins diet for use by parents with low levels of literacy in children with refractory epilepsy: A randomized controlled trial. Epilepsy Res. 2016;127:152–9.
   PubMed Web of Science ®Google Scholar
• Auvin S. Should we routinely use modified Atkins diet instead of regular ketogenic diet to treat children with epilepsy? Seizure. 2012;21(4):237–40.
   PubMed Web of Science ®Google Scholar
• Kim JA, Yoon JR, Lee EJ, Lee JS, Kim JT, Kim HD, et al. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia. 2016;57(1):51–8.
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Bosarge JL, Miranda MJ, Wiemer-Kruel A, Kang HC, Kim HD. Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet? Epilepsia. 2010;51(12):2496–9.
   PubMed Web of Science ®Google Scholar
• Pfeifer HH, Thiele EA. Low-glycemic-index treatment: A liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65(11):1810–2.
   PubMed Web of Science ®Google Scholar
• Muzykewicz DA, Lyczkowski DA, Memon N, Conant KD, Pfeifer HH, Thiele EA. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia. 2009;50(5):1118–26.
   PubMed Web of Science ®Google Scholar
• Miranda MJ, Turner Z, Magrath G. Alternative diets to the classical ketogenic diet—Can we be more liberal? Epilepsy Res. 2012;100(3):278–85.
   PubMed Web of Science ®Google Scholar
• Katyal NG, Koehler AN, McGhee B, Foley CM, Crumrine PK. The ketogenic diet in refractory epilepsy: the experience of children’s Hospital of Pittsburgh. Clin Pediatr (Phila). 2000;39(3):153–9.
   PubMed Web of Science ®Google Scholar
• Cai Q-Y, Zhou Z-J, Luo R, Gan J, Li S-P, Mu D-Z, et al. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017;13(6):528–36.
   PubMed Web of Science ®Google Scholar
• Maydell BV, Wyllie E, Akhtar N, Kotagal P, Powaski K, Cook K, et al. Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr Neurol. 2001;25(3):208–12.
   PubMed Web of Science ®Google Scholar
• Neal E, editor. Dietary treatment of epilepsy. Practical implementation of ketogenic therapy. Chichester: Wiley-Blackwall; 2012.
   Google Scholar
• Coppola G, Veggiotti P, Cusmai R, Bertoli S, Cardinali S, Dionisi-Vici C, et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res. 2002;48(3):221–7.
   PubMed Web of Science ®Google Scholar
• Vining EP. Clinical efficacy of the ketogenic diet. Epilepsy Res. 1999;37(3):181–90.
   PubMed Web of Science ®Google Scholar
• Titre-Johnson S, Schoeler N, Eltze C, Williams R, Vezyroglou K, McCullagh H, et al. Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trial. Trials. 2017;18(1):195.
   PubMed Web of Science ®Google Scholar
• Nordli DR, Kuroda MM, Carroll J, Koenigsberger DY, Hirsch LJ, Bruner HJ, et al. Experience with the ketogenic diet in infants. Pediatrics. 2001;108(1):129–33.
   PubMed Web of Science ®Google Scholar
• Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. The Lancet Neurology. 2008;7(6):500–6.
   PubMed Web of Science ®Google Scholar
• Schoeler NE, Wood S, Aldridge V, Sander JW, Cross JH, Sisodiya SM. Ketogenic dietary therapies for adults with epilepsy: feasibility and classification of response. Epilepsy Behav. 2014;37:77–81.
   PubMed Web of Science ®Google Scholar
• Payne NE, Cross JH, Sander JW, Sisodiya SM. The ketogenic and related diets in adolescents and adults—a review. Epilepsia. 2011;52(11):1941–8.
   PubMed Web of Science ®Google Scholar
• Phillips MCL. Ketogenic Diet Therapies in Children and Adults with Epilepsy. Epilepsy: IntechOpen; 2019.
   Google Scholar
• Meira IDA, Romão TT, do Prado HJP, Krüger LT, Pires MEP, da Conceição PO. Ketogenic diet and epilepsy: what we know so far. Front Neurosci. 2019;13:5.
   PubMed Web of Science ®Google Scholar
• Yellen G. Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet. Epilepsia. 2008;49(s8):80–2.
   PubMed Web of Science ®Google Scholar
• Baraban S. Neuropeptide Y and epilepsy: recent progress, prospects and controversies. Neuropeptides. 2004;38(4):261–5.
   PubMed Web of Science ®Google Scholar
• Barragan A, Weidner JM, Jin Z, Korpi E, Birnir B. GABAergic signalling in the immune system. Acta Physiol. 2015;213(4):819–27.
   PubMed Web of Science ®Google Scholar
• Calderón N, Betancourt L, Hernández L, Rada P. A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study. Neurosci Lett. 2017;642:158–62.
   PubMed Web of Science ®Google Scholar
• Dahlin M, Elfving Å, Ungerstedt U, Åmark P. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 2005;64(3):115–25.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Takahashi H, Fukuda M, Hino H, Kobayashi K, Tanaka J, et al. β-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res. 2009;1268:17–23.
   PubMed Web of Science ®Google Scholar
• Szot P, Weinshenker D, Rho JM, Storey TW, Schwartzkroin PA. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Dev Brain Res. 2001;129(2):211–4.
   PubMedGoogle Scholar
• Weinshenker D. The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet. Epilepsia. 2008;49(s8):104–7.
   PubMed Web of Science ®Google Scholar
• Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, et al. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science. 2001;292(5521):1543–6.
   PubMed Web of Science ®Google Scholar
• Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006;60(2):223–35.
   PubMed Web of Science ®Google Scholar
• Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007;48(1):43–58.
   PubMed Web of Science ®Google Scholar
• Li J, O’Leary EI, Tanner GR. The ketogenic diet metabolite beta-hydroxybutyrate (β-HB) reduces incidence of seizure-like activity (SLA) in a Katp-and GABAb-dependent manner in a whole-animal Drosophila melanogaster model. Epilepsy Res. 2017;133:6–9.
   PubMed Web of Science ®Google Scholar
• Piechotta PL, Rapedius M, Stansfeld PJ, Bollepalli MK, Erhlich G, Andres-Enguix I, et al. The pore structure and gating mechanism of K2P channels. EMBO J. 2011;30(17):3607–19.
   PubMed Web of Science ®Google Scholar
• Vamecq J, Vallée L, Lesage F, Gressens P, Stables JP. Antiepileptic popular ketogenic diet: emerging twists in an ancient story. Prog Neurobiol. 2005;75(1):1–28.
   PubMed Web of Science ®Google Scholar
• Hughes S, Foster RG, Peirson SN, Hankins MW. Expression and localisation of two-pore domain (K2P) background leak potassium ion channels in the mouse retina. Sci Rep. 2017;7:46085.
   PubMed Web of Science ®Google Scholar
• Franks NP, Honoré E. The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends Pharmacol Sci. 2004;25(11):601–8.
   PubMed Web of Science ®Google Scholar
• Khin PP, Zaw TS, Sohn UD. Signal transduction underlying the inhibitory mechanism of fluoxetine on electrical field stimulation response in rat ileal smooth muscle. Pharmacology. 2017;99(5-6):216–25.
   PubMed Web of Science ®Google Scholar
• Cheng CM, Hicks K, Wang J, Eagles DA, Bondy CA. Caloric restriction augments brain glutamic acid decarboxylase-65 and-67 expression. J Neurosci Res. 2004;77(2):270–6.
   PubMed Web of Science ®Google Scholar
• Erecińska M, Nelson D, Daikhin Y, Yudkoff M. Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J Neurochem. 1996;67(6):2325–34.
   PubMed Web of Science ®Google Scholar
• Melø TM, Nehlig A, Sonnewald U. Neuronal–glial interactions in rats fed a ketogenic diet. Neurochem Int. 2006;48(6-7):498–507.
   PubMed Web of Science ®Google Scholar
• Dahlin M, Månsson J-E, Åmark P. CSF levels of dopamine and serotonin, but not norepinephrine, metabolites are influenced by the ketogenic diet in children with epilepsy. Epilepsy Res. 2012;99(1-2):132–8.
   PubMed Web of Science ®Google Scholar
• Weinshenker D, Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther. 2002;94(3):213–33.
   PubMed Web of Science ®Google Scholar
• Tsuda K, Yokoo H, Goldstein M. Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices. Hypertension. 1989;14(1):81–6.
   PubMed Web of Science ®Google Scholar
• Mazarati AM. Galanin and galanin receptors in epilepsy. Neuropeptides. 2004;38(6):331–43.
   PubMed Web of Science ®Google Scholar
• Simeone TA, Matthews SA, Samson KK, Simeone KA. Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy. Exp Neurol. 2017;287:54–64.
   PubMed Web of Science ®Google Scholar
• Yoon J-R, Lee EJ, Kim HD, Lee JH, Kang H-C. Polyunsaturated fatty acid-enriched diet therapy for a child with epilepsy. Brain and Development. 2014;36(2):163–6.
   PubMed Web of Science ®Google Scholar
• Fraser D, Whiting S, Andrew R, Macdonald E, Musa-Veloso K, Cunnane S. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology. 2003;60(6):1026–9.
   PubMed Web of Science ®Google Scholar
• Taha A, Ryan MAA, Cunnane SC. Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metab, Clin Exp. 2005;54(9):1127–32.
   PubMed Web of Science ®Google Scholar
• Auvin S. Fatty acid oxidation and epilepsy. Epilepsy Res. 2012;100(3):224–8.
   PubMed Web of Science ®Google Scholar
• Kang JX. The importance of omega-6/omega-3 fatty acid ratio in cell function. Omega-6/Omega-3 Essential Fatty Acid Ratio: The Scientific Evidence. 2003;92:23–36.
   Google Scholar
• Wasik M, Mikula M, Bartyzel BJ, Strokowska N, Sablik P, Uca YO, et al. Polyunsaturated fatty acids in idiopathic epilepsy treatment in dogs. Acta Scientiarum Polonorum Zootechnica. 2016;15(2):3–10.
   Google Scholar
• Chang P, Terbach N, Plant N, Chen PE, Walker MC, Williams RS. Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology. 2013;69:105–14.
   PubMed Web of Science ®Google Scholar
• Dahlin M, Hjelte L, Nilsson S, Åmark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res. 2007;73(2):199–207.
   PubMed Web of Science ®Google Scholar
• Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004;55(4):576–80.
   PubMed Web of Science ®Google Scholar
• Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta. 2001;303(1-2):19–24.
   PubMed Web of Science ®Google Scholar
• Waldbaum S, Patel M. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 2010;88(1):23–45.
   PubMed Web of Science ®Google Scholar
• Milder J, Patel M. Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res. 2012;100(3):295–303.
   PubMed Web of Science ®Google Scholar
• Shin E-J, Jeong JH, Chung YH, Kim W-K, Ko K-H, Bach J-H, et al. Role of oxidative stress in epileptic seizures. Neurochem Int. 2011;59(2):122–37.
   PubMed Web of Science ®Google Scholar
• Dingledine R, Varvel NH, Dudek FE. When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? Adv Exp Med Biol. 2014;813:109–22.
   PubMed Web of Science ®Google Scholar
• Henshall D. Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy. Portland Press Limited. 2007;35:421–3.
   Google Scholar
• Fujikawa DG. Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav. 2005;7:3–11.
   Web of Science ®Google Scholar
• Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009;59(2):293–315.
   PubMedGoogle Scholar
• Hu ZG, Wang HD, Jin W, Yin HX. Ketogenic diet reduces cytochrome c release and cellular apoptosis following traumatic brain injury in juvenile rats. Annals of Clinical & Laboratory Science. 2009;39(1):76–83.
   PubMed Web of Science ®Google Scholar
• Shaafi S, Mahmoudi J, Pashapour A, Farhoudi M, Sadigh-Eteghad S, Akbari H. Ketogenic diet provides neuroprotective effects against ischemic stroke neuronal damages. Adv Pharm Bull. 2014;4(Suppl 2):479–81.
   PubMedGoogle Scholar
• Noh HS, Kang SS, Kim DW, Kim YH, Park CH, Han JY, et al. Ketogenic diet increases calbindin-D28k in the hippocampi of male ICR mice with kainic acid seizures. Epilepsy Res. 2005;65(3):153–9.
   PubMed Web of Science ®Google Scholar
• Noh HS, Kim DW, Kang SS, Cho GJ, Choi WS. Ketogenic diet prevents clusterin accumulation induced by kainic acid in the hippocampus of male ICR mice. Brain Res. 2005;1042(1):114–8.
   PubMed Web of Science ®Google Scholar
• Wang B-H, Hou Q, Lu Y-Q, Jia M-M, Qiu T, Wang X-H, et al. Ketogenic diet attenuates neuronal injury via autophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Res. 2018;1678:106–15.
   PubMed Web of Science ®Google Scholar